How does ChatGPT work? And its creator? Are you ready to cooperate with the vaccine?

Published Date: 16 Feb 2023

Chatbots have shields to control misinformation, but it will continue to be a game.

Read Full News

Latest News

AAN 2026: Key RRMS Clinical Trial Updates

Dr Chu-Yueh Guo discusses promising MS trial results, including a study of fenebrutinib and positive safety data for ocrelizumab in pregnancy and pediatric patients.

Are Smartwatches Changing Arrhythmia Care?

Wearables can flag AF and capture symptoms in real time — but who truly benefits? Cardiologist Walid Amara, MD, outlines where smartwatches fit in clinical practice.

Why the FDA Rejected RP-1 in Melanoma: A Data Deep Dive

Dr Bishal Gyawali unpacks the FDA’s decision to deny RP-1 in melanoma, exploring why single-arm data and confounded response rates failed to meet the bar for clinical evidence.

Does Healthy Living Best Antiamyloids for MCI, Early AD?

A combination of healthy lifestyle interventions may be better than amyloid-lowering medications in terms of protecting cognitive function, a new review suggests.

Valproate Tied to Higher Mortality in Dementia and Epilepsy

In older people with dementia and epilepsy, starting treatment with valproate is linked to a higher risk for deaths than starting treatment with other commonly used antiseizure medicines.

Surveillance Strategies for HCC: New Update

New AGA practice update addresses HCC risk stratification, surveillance, and emerging biomarkers.

Todays Updates

PSA Screening Overdiagnosis Rises Sharply With Age

About one third of cancers detected by PSA screening at age 70, and more than half at age 80, are unlikely to become clinically meaningful within 15 years.

Can Exercise Extend Survival After Breast Cancer?

A ‘target trial’ emulation study suggests that regular exercise can help breast cancer survivors live longer.

Liquid Biopsies Cut EBV Burkitt Lymphoma Time to Diagnosis

Broader implementation would require substantial investment, but long-term dividends of liquid biopsy analysis in the region could affect diagnosis and care of much more than just this cancer.

High Fruit, Veggie Diet Tied to Early-Onset Lung Cancer?

Counterintuitive findings hint that diets rich in fruit, vegetables, and whole grains may increase the risk of lung cancer in young nonsmokers, but experts are skeptical.

Photopenia on [18F]FDG PET/CT Predicts Benign Renal Lesions

Photopenia in high CT density renal lesions on [18F]FDG PET/CT scans shows a high negative predictive value for excluding malignancy.

Can Alternating Venetoclax Regimens Improve AML Outcomes?

A phase 2 study investigates the combination of cladribine plus low-dose cytarabine and venetoclax alternating with azacitidine plus venetoclax for newly diagnosed acute myeloid leukemia.

Vepdegestrant Earns FDA Nod for ESR1-Mutated Breast Cancer

Approval was based on findings from the phase 3 VERITAC-2 trial showing significantly improved PFS for patients with ESR1-mutated disease.

Todays Updates

PSA Screening Overdiagnosis Rises Sharply With Age

About one third of cancers detected by PSA screening at age 70, and more than half at age 80, are unlikely to become clinically meaningful within 15 years.

Can Exercise Extend Survival After Breast Cancer?

A ‘target trial’ emulation study suggests that regular exercise can help breast cancer survivors live longer.

Liquid Biopsies Cut EBV Burkitt Lymphoma Time to Diagnosis

Broader implementation would require substantial investment, but long-term dividends of liquid biopsy analysis in the region could affect diagnosis and care of much more than just this cancer.

High Fruit, Veggie Diet Tied to Early-Onset Lung Cancer?

Counterintuitive findings hint that diets rich in fruit, vegetables, and whole grains may increase the risk of lung cancer in young nonsmokers, but experts are skeptical.

Photopenia on [18F]FDG PET/CT Predicts Benign Renal Lesions

Photopenia in high CT density renal lesions on [18F]FDG PET/CT scans shows a high negative predictive value for excluding malignancy.

Can Alternating Venetoclax Regimens Improve AML Outcomes?

A phase 2 study investigates the combination of cladribine plus low-dose cytarabine and venetoclax alternating with azacitidine plus venetoclax for newly diagnosed acute myeloid leukemia.

Vepdegestrant Earns FDA Nod for ESR1-Mutated Breast Cancer

Approval was based on findings from the phase 3 VERITAC-2 trial showing significantly improved PFS for patients with ESR1-mutated disease.

Latest News

Dr Chu-Yueh Guo discusses promising MS trial results, including a study of fenebrutinib and positive safety data for ocrelizumab in pregnancy and pediatric patients.

Wearables can flag AF and capture symptoms in real time — but who truly benefits? Cardiologist Walid Amara, MD, outlines where smartwatches fit in clinical practice.

Dr Bishal Gyawali unpacks the FDA’s decision to deny RP-1 in melanoma, exploring why single-arm data and confounded response rates failed to meet the bar for clinical evidence.

A combination of healthy lifestyle interventions may be better than amyloid-lowering medications in terms of protecting cognitive function, a new review suggests.

In older people with dementia and epilepsy, starting treatment with valproate is linked to a higher risk for deaths than starting treatment with other commonly used antiseizure medicines.

New AGA practice update addresses HCC risk stratification, surveillance, and emerging biomarkers.

News All Time

How Hospitalists Can Expand Their Specialist Network

Knowing the right people to refer patients to is an important part of the job.

Burn Pit Exposure Linked to Higher Neurologic Risk in Vets

A study of 245,000 veterans shows burn pit exposure is tied to higher rates of neurologic disorders, with headaches and vertigo driving the increase.

Wildfire Smoke Linked to Potential Risks for Some Cancers

An analysis of the PLCO Cancer Screening Trial detected linear dose-response relationships between wildfire smoke exposure and risks for hematopoietic, bladder, breast, colorectal, and lung cancer.

EHR Burden in Oncology Is Taking a Toll. Is There a Fix?

As the documentation burden grows and patient portals overflow, oncologists are hoping to preserve what matters most — the relationship with their patients.

Prolonged Latency After Term PROM Tied to Maternal Infection

Latency beyond 12 hours after term prelabour rupture of membranes is independently linked to a higher likelihood of maternal intrauterine infection, even with active management.

FDA OKs Lumateperone for Schizophrenia Relapse Prevention

Long-term data show the atypical antipsychotic reduced relapse risk by 63%, with 84% of patients with schizophrenia being relapse-free over 6 months.

Are First-Time Seizures a Red Flag for Cancer?

A new study explores whether first-time seizures are associated with a higher risk for cancer in the short or long term.

UK Clinical Trial Regulations Come Into Force

New UK clinical trial rules come into force today, cutting set-up times by more than a quarter and making trial registration mandatory.

Zanubrutinib May Have PFS Edge Over Combo Therapy in CLL

A post hoc analysis evaluates zanubrutinib vs acalabrutinib-venetoclax in treatment naive chronic lymphocytic leukemia using indirect comparisons of data from two phase 3 trials.

Text Reminders Outperform Nurse Calls for CRC Screening

Automated text message reminders with embedded behavioral nudges are linked to higher colorectal cancer screening completion rates than reminder phone calls from nurses.

Treatment Delays for Metastatic Breast Cancer Vary by Race

Researchers conducted a retrospective cross-sectional analysis of patients diagnosed with de novo metastatic breast cancer to evaluate presentation and treatment differences across three main subtypes.

Smartphone Expands Options for Hearing Screening in Infants

Advantages include low cost and ease of use in diverse clinical settings.

Sleep Aid Use: Like Mother, Like Toddler

Despite a lack of safety data, maternal sleep aid use is linked to increased use in young children.

Three Psychiatric Emergencies Most Clinicians Misdiagnose

Delirium, alcohol and benzodiazepine withdrawal, and catatonia are often mistaken for psychiatric illness. Dr Adjoa Smalls-Mantey explains how to recognize them before they become life-threatening.

Risk of Second Primary Cancers After Early Breast Cancer

New data quantify the long-term risk of second cancers post-breast cancer. Dr Maurie Markman explores 20-year outcomes and the modest impact of prior systemic therapies.

Anemia Linked to Alzheimer’s Biomarkers, Dementia Risk

Older adults with anemia had 66% higher odds of developing dementia, with those with elevated Alzheimer’s disease blood biomarkers at highest risk.

Recommended News For You

An Intimate Life of Medical Innovation and Charity.

HER2 ADC Shows Promise in Recurrent Endometrial Cancer

No Benefit for PD-1 Inhibitors in Certain Gastroesophageal Cancers, FDA Panel Says

Novel Psychedelic Promising on Resistant Depression

Thriving while surviving: Understanding the social needs of cancer survivors

These Athletes Weren't Doping. Their Genes Made It Look Like They Did.

Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?

Recommended Articles For You

The Latest Advances in Glioblastoma Treatment and Prevention  

A Novel Gemcitabine-Releasing Intravesical System for Intermediate-Risk Non-Muscle-Invasive Bladder Cancer 

Survival Rates in Cancer: Focus on Acute Myeloid Leukemia and Other Malignancies 

Understanding Sickle Cell Anemia: Causes, Symptoms, and Treatment Options  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

FDA OKs Subcutaneous Daratumumab Plus VRd for Myeloma

2.

The Early Progression of Prostate Cancer Is Not Stopped by Metformin.

3.

Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease

4.

Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer

5.

Tipiracil hydrochloride and trifluridine tablets are approved by the USFDA for Natco Pharma.

1.

Understanding Adenomyosis: The Role of Ultrasound in Diagnosis Introduction

2.

Undersanding Alemtuzumab: What You Need To Know About This Multiple Sclerosis Medication

3.

Understanding Iron Saturation Levels in Your Blood 

4.

Beyond the Tumor: Emerging Frontiers in Cancer Systems Biology

5.

Subarachnoid Hemorrhage: Emerging Insights into Pathophysiology and Future Management

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion

2.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV

3.

CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World

4.

Should We Use DARA Up Front As First-Line Therapy in MM? - Part II

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot